Evidence for the management of adolescent depression

Pediatrics

Volumn 132, Issue 4, 2013, Pages

  Eric Lewandowski, R ^a   Acri, Mary C ^a   Hoagwood, Kimberly E ^a   Olfson, Mark ^b,c   Clarke, Greg ^d   Gardner, William ^e,f   Scholle, Sarah Hudson ^g   Byron, Sepheen ^g   Kelleher, Kelly ^f,h   Pincus, Harold A ^b,i,j,k   Frank, Samantha ^a   Horwitz, Sarah M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Psychiatry ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e DALHOUSIE UNIVERSITY   (Canada)

^f OHIO STATE UNIVERSITY   (United States)

^g NATIONAL COMMITTEE FOR QUALITY ASSURANCE   (United States)

^h NATIONWIDE CHILDREN S HOSPITAL   (United States)

ⁱ Och Spine at New York Presbyterian Hospitals   (United States)

^j NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^k RAND CORPORATION   (United States)

more..

Author keywords

Adolescents; Depression; Health care policy; Primary care; Quality measurement

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; CHILD PSYCHIATRY; CLINICAL DECISION MAKING; COGNITIVE THERAPY; DEPRESSION; DISEASE SEVERITY; DRUG MONITORING; DSM-IV-TR; EVIDENCE BASED MEDICINE; HUMAN; MENTAL HEALTH CARE; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; SCREENING TEST; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADOLESCENTS; DEPRESSION; HEALTH CARE POLICY; PRIMARY CARE; QUALITY MEASUREMENT;

ADOLESCENT; DEPRESSION; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES AS TOPIC; QUALITY INDICATORS, HEALTH CARE;

EID: 84885162572     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0600     Document Type: Article

References (155)

1. Haden A, Campanini B. The World Health Report 2001: Mental health: new understanding, new hope Geneva: World Health Organization (WHO); 2001
2. Kessler RC, Avenevoli S, Ries Merikangas K. Mood disorders in children and adolescents: an epidemiologic perspective. Biol Psychiatry. 2001;49(12):1002-1014
3. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol. 1993;102(1):133-144
4. Merikangas KR, He J-P, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49 (10):980-989
5. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev. 1998;18(7): 765-794
6. Zisook S, Lesser I, Stewart JW, et al. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007;164(10):1539-1546
7. Centers for Disease Control and Prevention. Depression. 2011. Available at: www.cdc.gov/mentalhealth/basics/mental-illness/depression.htm. Accessed September 15, 2011
8. Asarnow JR, Jaycox LH, Duan N, et al. Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. JAMA. 2005;293(3):311-319
9. Shaffer D, Gould MS, Fisher P, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry. 1996;53(4):339-348
10. Brent DA, Baugher M, Bridge JA, Chen T, Chiappetta L. Age- and sex-related risk factors for adolescent suicide. J Am Acad Child Adolesc Psychiatry. 1999;38(12): 1497-1505
11. Grøholt B, Ekeberg O, Wichstrøm L, Haldorsen T. Suicide among children and younger and older adolescents in Norway: a comparative study. J Am Acad Child Adolesc Psychiatry. 1998;37(5):473-481
12. Moskos M, Olson L, Halbern S, Keller T, Gray D. Utah youth suicide study: psychological autopsy. Suicide Life Threat Behav. 2005;35(5):536-546
13. Gould MS, King R, Greenwald S, et al. Psychopathology associated with suicidal ideation and attempts among children and adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37(9):915-923
14. Wunderlich U, Bronisch T, Wittchen HU. Comorbidity patterns in adolescents and young adults with suicide attempts. Eur Arch Psychiatry Clin Neurosci. 1998;248 (2):87-95
15. Mandell DS, Guevara JP, Rostain AL, Hadley TR. Economic grand rounds: medical expenditures among children with psychiatric disorders in a Medicaid population. Psychiatr Serv. 2003;54(4):465-467
16. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety. 1998;7(1):3-14
17. Kataoka SH, Zhang L, Wells KB. Unmet need for mental health care among US children: variation by ethnicity and insurance status. Am J Psychiatry. 2002;159(9):1548-1555
18. Kataoka SH, Stein BD, Lieberman R, Wong M. Datapoints: suicide prevention in schools: are we reaching minority youths? Psychiatr Serv. 2003;54(11):1444
19. Merikangas KR, He JP, Burstein M, et al. Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2011;50(1):32-45
20. Horwitz SM, Kelleher K, Boyce T, et al. Barriers to health care research for children and youth with psychosocial problems. JAMA. 2002;288(12):1508-1512
21. Horwitz SM, Leaf PJ, Leventhal JM, Forsyth B, Speechley KN. Identification and management of psychosocial and developmental problems in community-based, primary care pediatric practices. Pediatrics. 1992;89(3): 480-485
22. Kramer T, Garralda ME. Psychiatric disorders in adolescents in primary care. Br J Psychiatry. 1998;173(6):508-513
23. Chang G, Warner V, Weissman MM. Physicians' recognition of psychiatric disorders in children and adolescents. Am J Dis Child. 1988;142(7):736-739
24. Olson AL, Kelleher KJ, Kemper KJ, Zuckerman BS, Hammond CS, Dietrich AJ. Primary care pediatricians' roles and perceived responsibilities in the identification and management of depression in children and adolescents. Ambul Pediatr. 2001;1(2):91-98
25. Foy JM; American Academy of Pediatrics Task Force on Mental Health. Enhancing pediatric mental health care: algorithms for primary care. Pediatrics. 2010;125 (suppl 3):S109-S125
26. Jellinek MS, Patel BP, Froehle MC. Bright Futures in Practice: Mental Health. Arlington, VA: National Center for Education in Maternal and Child Health, Georgetown University; 2002
27. The State of Health Care Quality: Reform, the Quality Agenda and Resource Use. Washington, DC: National Committee for Quality Assurance; 2010
28. Zima BT, Mangione-Smith R. Gaps in quality measures for child mental health care: an opportunity for a collaborative agenda. J Am Acad Child Adolesc Psychiatry. 2011;50(8):735-737
29. Wobrock T, Weinmann S, Falkai P, Gaebel W. Quality assurance in psychiatry: quality indicators and guideline implementation. Eur Arch Psychiatry Clin Neurosci. 2009; 259(suppl 2):S219-S226
30. Zima BT, Murphy JM, Scholle SH, et al. National quality measures for child mental health care: background, progress, and next steps. Pediatrics. 2013;131(suppl 1):S38-S49
31. Scholle SH, Sampsel SL, Davis ME, Schor EL. Quality of Child Health Care: Expanding the Scope and Flexibility of Measurement Approaches. Commonwealth Fund; 2009
32. Noser K, Bickman L. Quality indicators of children's mental health services: do they predict improved client outcomes? J Emot Behav Disord. 2000;8(1):9-18
33. US Preventive Services Task Force. Screening and treatment for major depressive disorder in children and adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics. 2009;123(4):1223-1228
34. National Institute for Health and Clinical Excellence. Clinical Guideline 28: Depression in Children and Young People: Identification and Management in Primary, Community, and Secondary Care. London, UK: NHS; 2005
35. Birmaher B, Brent D, Bernet W, et al; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46(11):1503-1526
36. American Medical Association. Guidelines for Adolescent Preventive Services (GAPS): Recommendations Monograph. Chicago, IL: American Medical Association; 1997
37. Klein JD, Allan MJ, Elster AB, et al. Improving adolescent preventive care in community health centers. Pediatrics. 2001;107(2):318-327
38. Halpern-Felsher BL, Ozer EM, Millstein SG, et al. Preventive services in a health maintenance organization: how well do pediatricians screen and educate adolescent patients? Arch Pediatr Adolesc Med. 2000;154(2):173-179
39. Allgaier A-K, Pietsch K, Frühe B, Sigl-Glöckner J, Schulte-Körne G. Screening for depression in adolescents: validity of the patient health questionnaire in pediatric care. Depress Anxiety. 2012;29(10):906-913
40. Johnson JG, Harris ES, Spitzer RL, Williams JB. The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30(3):196-204
41. Richardson LP, McCauley E, Grossman DC, et al. Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents. Pediatrics. 2010;126(6):1117-1123
42. Richardson LP, Rockhill C, Russo JE, et al. Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics. 2010;125(5). Available at: www.pediatrics.org/cgi/content/full/125/5/e1097
43. Winter LB, Steer RA, Jones-Hicks L, Beck AT. Screening for major depression disorders in adolescent medical outpatients with the Beck Depression Inventory for Primary Care. J Adolesc Health. 1999;24(6):389-394
44. Williams SB, O'Connor EA, Eder M, Whitlock EP. Screening for child and adolescent depression in primary care settings: a systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2009;123(4). Available at: www.pediatrics.org/cgi/content/full/123/4/e716
45. Aseltine RH Jr, DeMartino R. An outcome evaluation of the SOS suicide prevention program. Am J Public Health. 2004;94(3):446-451
46. Aseltine RH Jr, James A, Schilling EA, Glanovsky J. Evaluating the SOS suicide prevention program: a replication and extension. BMC Public Health. 2007;7(1):161
47. Zuckerbrot RA, Cheung AH, Jensen PS, Stein REK, Laraque D; GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, assessment, and initial management. Pediatrics. 2007;120(5). Available at: www.pediatrics.org/cgi/content/full/120/5/e1299
48. Ariza MA, Merino GA, Linero EH, et al. Clinical Practice Guideline on Major Depression in Childhood and Adolescence. Madrid, Spain: Ministry of Health and Social Policy, Galician Health Technology Assessment Agency; 2010
49. Cincinnati Children's Hospital Medical Center. Best Evidence Statement (BESt): Treatment of Children and Adolescents With Major Depressive Disorder (MDD) During the Acute Phase. Cincinnati, OH: Cincinnati Children's Hospital Medical Center; 2010
50. Cheung AH, Zuckerbrot RA, Jensen PS, Ghalib K, Laraque D, Stein REK; GLAD-PC Steering Group. Guidelines for adolescent depression in primary care (GLAD-PC): II. Treatment and ongoing management. Pediatrics. 2007;120(5). Available at: www.pediatrics.org/cgi/content/full/120/5/e1313
51. Mash EJ, Hunsley J. Evidence-based assessment of child and adolescent disorders: issues and challenges. J Clin Child Adolesc Psychol. 2005;34(3):362-379
52. Angold A, Prendergast M, Cox A, Harrington R, Simonoff E, Rutter M. The child and adolescent psychiatric assessment (CAPA). Psychol Med. 1995;25(4):739-753
53. Hodges K, Bickman L, Ring-Kurtz S, Reiter M. Multidimensional Measure of Level of Functioning for Children and Adolescents. A System of Care for Children's Mental Health: Expanding the Research Base. Tampa, FL: Research Training Center for Children's Mental Health; 1991:149-154
54. Kaufman J, Birmaher B, Brent DA, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980-988
55. Kessler RC, Avenevoli S, Costello EJ, et al. National comorbidity survey replication adolescent supplement (NCS-A): II. Overview and design. J Am Acad Child Adolesc Psychiatry. 2009;48(4):380-385
56. Orvaschel H, Puig-Antich J, Chambers W, Tabrizi MA, Johnson R. Retrospective assessment of prepubertal major depression with the Kiddie-SADS-e. J Am Acad Child Psychiatry. 1982;21(4):392-397
57. Shaffer D, Fisher P, Dulcan MK, et al. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study. J Am Acad Child Adolesc Psychiatry. 1996;35(7):865-877
58. Angold A, Costello EJ. A test-retest reliability study of child-reported psychiatric symptoms and diagnoses using the Child and Adolescent Psychiatric Assessment (CAPA-C). Psychol Med. 1995;25(4):755-762
59. Ebesutani C, Bernstein A, Chorpita BF, Weisz JR. A transportable assessment protocol for prescribing youth psychosocial treatments in real-world settings: reducing assessment burden via self-report scales. Psychol Assess. 2012;24(1):141-155
60. Gibbons RD, Weiss DJ, Kupfer DJ, et al. Using computerized adaptive testing to reduce the burden of mental health assessment. Psychiatr Serv. 2008;59(4):361-368
61. Nordström P, Samuelsson M, Åsberg M. Survival analysis of suicide risk after attempted suicide. Acta Psychiatr Scand. 1995;91(5):336-340
62. Brown GK, Beck AT, Steer RA, Grisham JR. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol. 2000;68(3):371-377
63. Kuo WH, Gallo JJ, Tien AY. Incidence of suicide ideation and attempts in adults: the 13-year follow-up of a community sample in Baltimore, Maryland. Psychol Med. 2001;31(7):1181-1191
64. Nock MK, Green JG, Hwang I, et al. Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents. JAMA Psychiatry, 2013;7(3):300-310
65. Healy DJ, Barry K, Blow F, Welsh D, Milner KK. Routine use of the Beck Scale for Suicide Ideation in a psychiatric emergency department. Gen Hosp Psychiatry. 2006;28(4):323-329
66. Malone KM, Szanto K, Corbitt EM, Mann JJ. Clinical assessment versus research methods in the assessment of suicidal behavior. Am J Psychiatry. 1995;152(11):1601-1607
67. Bongiovi-Garcia ME, Merville J, Almeida MG, et al. Comparison of clinical and research assessments of diagnosis, suicide attempt history and suicidal ideation in major depression. J Affect Disord. 2009; 115(1-2):183-188
68. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007; 164(7):1035-1043
69. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266-1277
70. Renaud J, Brent DA, Baugher M, Birmaher B, Kolko DJ, Bridge J. Rapid response to psychosocial treatment for adolescent depression: a two-year follow-up. J Am Acad Child Adolesc Psychiatry. 1998;37(11):1184-1190
71. Brettle A, Hill A, Jenkins P. Counselling in primary care: a systematic review of the evidence. Counselling and Psychotherapy Research. 2008;8(4):207-214
72. Bower P, Rowland N, Hardy R. The clinical effectiveness of counselling in primary care: a systematic review and meta-analysis. Psychol Med. 2003;33(2):203-215
73. Nieuwsma JA, Trivedi RB, McDuffie J, Kronish I, Benjamin D, Williams JW. Brief psychotherapy for depression: a systematic review and meta-analysis. Int J Psychiatry Med. 2012;43(2):129-151
74. Chorpita BF, Daleiden EL. Mapping evidence-based treatments for children and adolescents: application of the distillation and matching model to 615 treatments from 322 randomized trials. J Consult Clin Psychol. 2009;77(3):566-579
75. Weisz JR, Chorpita BF, Palinkas LA, et al; Research Network on Youth Mental Health. Testing standard and modular designs for psychotherapy treating depression, anxiety, and conduct problems in youth: a randomized effectiveness trial. Arch Gen Psychiatry. 2012;69(3):274-282
76. Townsend E, Hawton K, Altman DG, et al. The efficacy of problem-solving treatments after deliberate self-harm: metaanalysis of randomized controlled trials with respect to depression, hopelessness and improvement in problems. Psychol Med. 2001;31(6):979-988
77. Cuijpers P, Van Straten A, Warmerdam L, Smits N. Characteristics of effective psychological treatments of depression: a metaregression analysis. Psychother Res. 2008; 18(2):225-236
78. Bell AC, D'Zurilla TJ. Problem-solving therapy for depression: a meta-analysis. Clin Psychol Rev. 2009;29(4):348-353
79. Lerner MS, Clum GA. Treatment of suicide ideators: a problem-solving approach. Behav Ther. 1990;21(4):403-411
80. Kennard BD, Clarke GN, Weersing VR, et al. Effective components of TORDIA cognitivebehavioral therapy for adolescent depression: preliminary findings. J Consult Clin Psychol. 2009;77(6):1033-1041
81. Fitzpatrick KK, Witte TK, Schmidt NB. Randomized controlled trial of a brief problemorientation intervention for suicidal ideation. Behav Ther. 2005;36(4):323-333
82. Van Voorhees BW, Fogel J, Reinecke MA, et al. Randomized clinical trial of an Internetbased depression prevention program for adolescents (Project CATCH-IT) in primary care: 12-week outcomes. J Dev Behav Pediatr. 2009;30(1):23-37
83. Cuijpers P, Muñoz RF, Clarke GN, Lewinsohn PM. Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later. Clin Psychol Rev. 2009;29(5):449-458
84. Cuijpers P. A psychoeducational approach to the treatment of depression: a meta-analysis of Lewinsohn's "Coping With Depression" course. Behav Ther. 1998;29(3):521-533
85. Clarke GN, Rohde P, Lewinsohn PM, Hops H, Seeley JR. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry. 1999;38(3):272-279
86. Clarke GN, DeBar LL, Lewinsohn PM. Cognitive-behavioral group treatment for adolescent depression. In: Kazdin AE, Weisz, JR eds. Evidence-based psychotherapies for children and adolescents. New York, NY: Guilford Press; 2003: 120-134
87. Rohde P, Lewinsohn PM, Clarke GN, Hops H, Seeley JR. The Adolescent Coping With Depression Course: A Cognitive-Behavioral Approach to the Treatment of Adolescent Depression. In: Hibbs ED, Jensen, PS eds. Psychosocial Treatments for Child and Adolescent Disorders: Empirically Based Strategies for Clinical Practice. 2nd ed. Washington, DC: American Psychological Association; 2005: 219-237
88. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry. 2005;46(7):735-754
89. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007; 297(15):1683-1696
90. Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN. Newer generation antidepressants for depressive disorders in children and adolescents. Cochrane Database Syst Rev. 2012
91. Tsapakis EM, Soldani F, Tondo L, Baldessarini RJ. Efficacy of antidepressants in juvenile depression: meta-analysis. Br J Psychiatry. 2008;193(1):10-17
92. Usala T, Clavenna A, Zuddas A, Bonati M. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis. Eur Neuropsychopharmacol. 2008;18(1):62-73
93. Lewinsohn PM, Clarke GN, Hops H, Andrews J. Cognitive-behavioral treatment for depressed adolescents. Behav Ther. 1990;21(4):385-401
94. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 2004;61(6):577-584
95. March J, Silva S, Petrycki S, et al; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitivebehavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820
96. Brent DA, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913
97. Sia C, Antonelli RC, Gupta VB, et al. The medical home. Pediatrics. 2002;110(1):184-186
98. Sia C, Tonniges TF, Osterhus E, Taba S. History of the medical home concept. Pediatrics. 2004;113(suppl 5):1473-1478
99. Antonelli RC, McAllister JW, Popp J, Fund C. Making Care Coordination a Critical Component of the Pediatric Health System: A Multidisciplinary Framework. New York, NY: Commonwealth Fund; 2009
100. Cooley WC. Redefining primary pediatric care for children with special health care needs: the primary care medical home. Curr Opin Pediatr. 2004;16(6):689-692
101. McInerny T. The role of the general pediatrician in coordinating the care of children with chronic illness. Pediatr Clin North Am. 1984;31(1):199-209
102. Stille CJ, Antonelli RC. Coordination of care for children with special health care needs. Curr Opin Pediatr. 2004;16(6):700-705
103. Stille CJ, Primack WA, Savageau JA. Generalist-subspecialist communication for children with chronic conditions: a regional physician survey. Pediatrics. 2003; 112(6):1314-1320
104. Gupta VB, O'Connor KG, Quezada-Gomez C. Care coordination services in pediatric practices. Pediatrics. 2004;113(suppl 5):1517-1521
105. Strickland B, McPherson M, Weissman G, Dyck PV, Huang ZJ, Newacheck P. Access to the medical home: results of the National Survey of Children With Special Health Care Needs. Pediatrics. 2004;113(suppl 4):1485-1492
106. Patrick G, Bisgaier J, Hasham I, Navarra T, Hickner J. Specialty care referral patterns for the underserved: a study of community health centers on the South Side of Chicago. J Health Care Poor Underserved. 2011;22(4):1302-1314
107. Rushton J, Bruckman D, Kelleher K. Primary care referral of children with psychosocial problems. Arch Pediatr Adolesc Med. 2002; 156(6):592-598
108. Farmer JE, Clark MJ, Drewel EH, Swenson TM, Ge B. Consultative care coordination through the medical home for CSHCN: a randomized controlled trial. Matern Child Health J. 2011;15(7):1110-1118
109. Palfrey JS, Sofis LA, Davidson EJ, Liu J, Freeman L, Ganz ML. The Pediatric Alliance for Coordinated Care: evaluation of a medical home model. Pediatrics. 2004;113 (suppl 4):1507-1516
110. Unützer J, Katon W, Callahan CM, et al; IMPACT Investigators. Improving Mood-Promoting Access to Collaborative Treatment. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288(22):2836-2845
111. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166(21):2314-2321
112. Howard KI, Kopta SM, Krause MS, Orlinsky DE. The dose-effect relationship in psychotherapy. Am Psychol. 1986;41(2):159-164
113. Barkham M, Rees A, Shapiro DA, et al. Outcomes of time-limited psychotherapy in applied settings: replicating the Second Sheffield Psychotherapy Project. J Consult Clin Psychol. 1996;64(5):1079-1085
114. Barkham M, Rees A, Stiles WB, Hardy GE, Shapiro DA. Dose-effect relations for psychotherapy of mild depression: a quasiexperimental comparison of effects of 2, 8, and 16 sessions. Psychother Res. 2002; 12(4):463-474
115. Molenaar PJ, Boom Y, Peen J, Schoevers RA, Van R, Dekker JJ. Is there a dose-effect relationship between the number of psychotherapy sessions and improvement of social functioning? Br J Clin Psychol. 2011; 50(3):268-282
116. Dekker J, Molenaar PJ, Kool S, Van Aalst G, Peen J, de Jonghe F. Dose-effect relations in time-limited combined psychopharmacological treatment for depression. Psychol Med. 2005;35(1):47-58
117. Clarke G, Debar L, Lynch F, et al. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry. 2005;44(9):888-898
118. Weisz JR, Thurber CA, Sweeney L, Proffitt VD, LeGagnoux GL. Brief treatment of mild-tomoderate child depression using primary and secondary control enhancement training. J Consult Clin Psychol. 1997;65(4):703-707
119. Trivedi MH, Rush AJ, Crismon ML, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004;61(7):669-680
120. Sakolsky DJ, Perel JM, Emslie GJ, et al. Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study. J Clin Psychopharmacol. 2011;31(1):92-97
121. Bickman L. A measurement feedback system (MFS) is necessary to improve mental health outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(10):1114- 1119
122. Garland AF, Haine-Schlagel R, Brookman-Frazee L, Baker-Ericzen M, Trask E, Fawley-King K. Improving community-based mental health care for children: translating knowledge into action. Adm Policy Ment Health. 2013;40(1):6-22
123. Garland AF, Kruse M, Aarons GA. Clinicians and outcome measurement: what's the use? J Behav Health Serv Res. 2003;30(4):393-405
124. Bickman L, Kelley SD, Breda C, de Andrade AR, Riemer M. Effects of routine feedback to clinicians on mental health outcomes of youths: results of a randomized trial. Psychiatr Serv. 2011;62(12):1423-1429
125. Lambert MJ, Whipple JL, Hawkins EJ, Vermeersch DA, Nielsen SL, Smart DW. Is it time for clinicians to routinely track patient outcome? A meta-analysis. Clinical Psychology: Science and Practice. 2003;10(3):288-301
126. Shimokawa K, Lambert MJ, Smart DW. Enhancing treatment outcome of patients at risk of treatment failure: meta-analytic and mega-analytic review of a psychotherapy quality assurance system. J Consult Clin Psychol. 2010;78(3):298-311
127. Knaup C, Koesters M, Schoefer D, Becker T, Puschner B. Effect of feedback of treatment outcome in specialist mental healthcare: meta-analysis. Br J Psychiatry. 2009;195(1):15-22
128. Ansseau M, Demyttenaere K, Heyrman J, Migeotte A, Leyman S, Mignon A. Objective: remission of depression in primary care The Oreon Study. Eur Neuropsychopharmacol. 2009;19(3):169-176
129. Nierenberg AA, Wright EC. Evolution of remission as the new standard in the treatment of depression. J Clin Psychiatry. 1999;60(suppl 22):7-11
130. Emslie GJ, Heiligenstein JH, Wagner KD, et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1205-1215
131. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54(11):1031-1037
132. Wagner KD, Berard R, Stein MB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry. 2004;61(11):1153-1162
133. Brent DA, Holder D, Kolko D, et al. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Arch Gen Psychiatry. 1997;54(9):877-885
134. Compton SN, March JS, Brent D, Albano AM V, Weersing R, Curry J. Cognitivebehavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43(8):930-959
135. Clarke GN, Hornbrook M, Lynch F, et al. Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization. J Am Acad Child Adolesc Psychiatry. 2002;41(3):305-313
136. Vostanis P, Feehan C, Grattan E, Bickerton WL. A randomised controlled out-patient trial of cognitive-behavioural treatment for children and adolescents with depression: 9-month follow-up. J Affect Disord. 1996;40 (1-2):105-116
137. Wood A, Harrington R, Moore A. Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry. 1996;37(6):737-746
138. Cornwall PL, Scott J. Partial remission in depressive disorders. Acta Psychiatr Scand. 1997;95(4):265-271
139. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry. 1998;55(12):1128-1132
140. Sood N, Treglia M, Obenchain RL, Dulisse B, Melfi CA, Croghan TW. Determinants of antidepressant treatment outcome. Am J Manag Care. 2000;6(12):1327-1336
141. Claxton AJ, Li Z, McKendrick J. Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression. Br J Psychiatry. 2000;177(2):163-168
142. Pintor L, Gastó C, Navarro V, Torres X, Fañanas L. Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Disord. 2003;73(3):237-244
143. Pintor L, Torres X, Navarro V, Matrai S, Gastó C. Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? J Affect Disord. 2004;82(2):291-296
144. Judd LL, Akiskal HS, Zeller PJ, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psychiatry. 2000;57(4):375-380
145. Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry. 2000;157(9):1501-1504
146. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA. 2003;289(23):3152-3160
147. Paykel ES. Remission and residual symptomatology in major depression. Psychopathology. 1998;31(1):5-14
148. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25(6):1171-1180
149. Hepner KA, Rowe M, Rost K, et al. The effect of adherence to practice guidelines on depression outcomes. Ann Intern Med. 2007;147(5):320-329
150. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend. 2007;88(suppl 2):S61-S71
151. Gaynes BN, Dusetzina SB, Ellis AR, et al. Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STARD. J Clin Psychopharmacol. 2012;32(1):114-119
152. Friedman ES, Thase M, Wisniewski S, et al. Cognitive therapy augmentation versus CT switch treatment: A STAR D Report. Int J Cogn Ther. 2009;2(1):66-87
153. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR D report. Am J Psychiatry. 2006;163(11):1905-1917
154. Harding KJ, Rush AJ, Arbuckle M, Trivedi MH, Pincus HA. Measurement-based care in psychiatric practice: a policy framework for implementation. J Clin Psychiatry. 2011;72(8):1136-1143
155. National Quality Forum. Electronic Quality Measures (eMeasures). National Quality Forum Website. Available at: http://www.qualityforum.org/Projects/e-g/ eMeasures/Electronic-Quality-Measures.aspx#t=1&s=&p=&e=1. Accessed October 12, 2012